SPOTLIGHT -
ASCO: Molecular Diagnostics Allow Further Understanding of Medulloblastoma
As part of our coverage of the 2014 American Society of Clinical Oncology (ASCO) Annual Meeting, we discuss how molecular diagnosis in medulloblastoma affects clinical decision-making.
